| James Gregory Bass, MD | |
|
1924 Pine St, Suite 401b, Abilene, TX 79601-2451 | |
| (325) 670-4242 | |
| (325) 670-4201 |
| Full Name | James Gregory Bass |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 1924 Pine St, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992725956 | NPI | - | NPPES |
| 115825504 | Medicaid | TX | |
| 115825501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | H6035 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faith Hospice Of Western Oklahoma | Elk city, OK | Hospice |
| Hendrick Medical Center | Abilene, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendrick Provider Network | 9739162181 | 231 |
News Archive
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
› Verified 5 days ago
| Entity Name | Privia Medical Group West Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346242567 PECOS PAC ID: 5597747378 Enrollment ID: O20040604000460 |
News Archive
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
› Verified 5 days ago
| Entity Name | Hendrick Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396961322 PECOS PAC ID: 9739162181 Enrollment ID: O20040609001047 |
News Archive
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
› Verified 5 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Gregory Bass, MD Po Box 1198, Abilene, TX 79604-1198 Ph: (325) 670-4220 | James Gregory Bass, MD 1924 Pine St, Suite 401b, Abilene, TX 79601-2451 Ph: (325) 670-4242 |
News Archive
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.
Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.
In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.
› Verified 5 days ago
Nicole C Bullock, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6250 Regional Plz, Suite 1010, Abilene, TX 79606 Phone: 325-428-5500 Fax: 325-428-5519 | |
Dr. Stuart Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 402, Abilene, TX 79601 Phone: 325-670-6860 Fax: 325-670-6861 | |
Dr. Jessica Ann Ortolano, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1850 Hickory St, Suite 200d, Abilene, TX 79601 Phone: 325-670-5385 Fax: 325-670-5389 | |
Jerry Sinclair, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1680 Antilley Rd, #380, Abilene, TX 79606 Phone: 325-691-1122 | |
Dr. Timothy Joseph Hill Ii, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St Ste 401b, Abilene, TX 79601 Phone: 325-670-4242 Fax: 833-437-1269 | |
Stefanie Bertie Mccain, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Hospital Dr, Abilene, TX 79606 Phone: 325-690-0620 Fax: 325-690-0622 | |
Dr. Katherine Hall Jelliffe, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1933 Pine St Ste A, Abilene, TX 79601 Phone: 325-692-0626 Fax: 325-692-0638 |